OpenAlex
PricingAboutJobs
Log inGet started
Work

Preliminary data from a multi-arm expansion study of MEDI4736, an anti-PD-L1 antibody.

HTML

Year: 2014
Type: conference-abstract
Source: Journal of Clinical Oncology
DOI: 10.1200/jco.2014.32.15_suppl.3002
Authors: Neil Howard Segal, Scott Joseph Antonia, Julie R. Brahmer, Michele Maio, Andy Blake-Haskins, Xia Li, Jim Vasselli, Ramy A. Ibrahim, Jose Lutzky, Samir Khleif
Institutions: Memorial Sloan Kettering Cancer Center, Moffitt Cancer Center, Johns Hopkins University, Sidney Kimmel Comprehensive Cancer Center, University of Siena, Mount Sinai Medical Center, Augusta University
Language: English

Topic: Cancer Immunotherapy and Biomarkers
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Keywords: durvalumab, PD-L1 inhibitors, PD-1/PD-L1 blockade, cancer immunotherapy, treatment safety, immune-related adverse events, pneumonitis, melanoma, non-small cell lung cancer, head and neck squamous cell carcinoma, gastroesophageal cancer, hepatocellular carcinoma, pancreatic cancer, triple-negative breast cancer, tumor response
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W2474401389
Cites:
Cited by: 178
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms